Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… CHLOROTHIAZIDE; RESERPINE Tablet; 250MG;0.125MG DIUPRES-250 MERCK 011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 500MG;0.125MG DIUPRES-500 MERCK 013636 POLYTHIAZIDE; RESERPINE Tablet; 2MG;0.25MG RENESE-R PFIZER 009838 BP RESERPINE Tablet; 0.1MG RESERPINE Eon 009838 BP RESERPINE Tablet; 0.25MG RESERPINE Eon 010124 BP RESERPINE Tablet; 0.1MG SERPALAN LANNETT 010124 BP RESERPINE Tablet; 0.25MG SERPALAN LANNETT ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com